Health-Related QoL Among Women Receiving Hysterectomy in NTUH

Learn more about:
Related Clinical Trial
Determination of the Incidence of Endometriosis and or Adenomyosis in Patients Diagnosed With Polycystic Ovary Syndrome, or the Incidence of Polycystic Ovary Syndrome in Patients Diagnosed With Endometriosis and or Adenomyosis The Effect of Adenomoyosis on Pregnancy Outcomes Observational Study of Patients Suffering From Endometriosis and Adenomyosis Factors Associated With Adenomyosis and a Clinical Scoring System for the Diagnosis Quality of Life After Hysterectomy (AdenoQOL) Low Molecular Weight Heparin on the Adenomyosis Patients’IVF-ET Outcome Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI Clinical and Molecular Study of Endometriosis and Adenomyosis Surgical Success After Laparoscopic vs Abdominal Hysterectomy Electronic Catheter Stethoscope Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? Single-port Access Laparoscopic-assisted Vaginal Hysterectomy Uterine Artery Embolization for Symptomatic Fibroids Oxytocin in MRI-HIFU To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy Effect of Addition of Steroids on Duration of Analgesia Paracervical Block in Laparoscopic Hysterectomy Use of Dexamethasone in Uterine Artery Embolization Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS) Dienogest for Treatment of Adenomyotic Uteri Health-Related QoL Among Women Receiving Hysterectomy in NTUH Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis Adenomyosis and Ulipristal Acetate Efficacy of Acupuncture on Chronic Pelvic Pain in Women With Endometriosis or Adenomyosis LNG-IUS for Treatment of Dysmenorrhea Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis Adenomyosis: Genomic Mechanisms and Biological Response What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis A Prospective Study of Diagnostic Accuracy of Ultrasound Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis A Multi-omics Study of Adenomyosis Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis Levonorgestrel Intrauterine System and Adenomyosis Validation of the Adenomyosis Calculator Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer. New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms High-intensity Focused Ultrasound in Treatment of Uterine Adenomyosis Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis Norwegian Adenomyosis Study III: Peristalsis Histopathological Diagnosis of Adenomyosis Norwegian Adenomyosis Study I Vaginal Bromocriptine for Treatment of Adenomyosis Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis

Brief Title

Health-Related QoL Among Women Receiving Hysterectomy in NTUH

Official Title

Health-Related Quality of Life Among Women Receiving Hysterectomy in National Taiwan University Hospital

Brief Summary

      Laparoscopic assisted vaginal hysterectomy (LAVH)has become the most prevalent operation
      method in woman suffering from uterine myoma or adenomyosis nowadays. The operation decisions
      for these women are always due to symptoms such as pain, anemia and mass effect. However,
      there is a lack of measurement for these symptoms and therefore highlight the need to
      validate these symptom by health-related quality of life (QOL) assessments. Patients usually
      recovered better by LAVH comparing to traditional open surgeries. However, LAVH was
      restricted to cases with small size uteri and most QOL reported neglected uterine weight or
      were based on small uteri size. We recently intervened a new surgical procedure called RULU
      during LAVH and thus released this limitation. This will give a more unbiased study on the
      effect of QOL in patients receiving LAVH. In this study, we plan to use two questionnaires:
      the disease specific UFS-QOL and the WHO-QOL Taiwan version questionnaires for patients
      receiving LAVH. Assessment will be performed before operation; and 3 days, 7 days, 3 months
      and 18 months after operation. From these assessments, we plan to determine which QOL
      variables will be useful as operation guidelines for patients suffering from leiomyoma or
      adenomyosis, and for the assessment of appropriates and outcomes of LAVH.
    

Detailed Description

      Hysterectomy is the most common non-pregnancy-related surgical procedure performed in women
      in Taiwan. There are three surgical approaches to hysterectomy: abdominal, vaginal and
      laparoscopic assisted vaginal hysterectomy (LAVH) and LAVH has become the most prevalent
      operation method in woman suffering from uterine myoma or adenomyosis nowadays. The operation
      decisions for these women are always due to symptoms such as pain, anemia and mass effect.
      However, there is a lack of measurement for these symptoms and therefore highlight the need
      to validate these symptom by health-related quality of life (QOL) assessments. Patients
      usually recovered better by LAVH comparing to traditional open surgeries. However, LAVH was
      restricted to cases with small size uteri and most QOL reported neglected uterine weight or
      were based on small uteri size. We recently intervened a new surgical procedure called RULU
      during LAVH and thus released this limitation. This will give a more unbiased study on the
      effect of QOL in patients receiving LAVH. In this study, we plan to use two questionnaires:
      the disease specific UFS-QOL and the WHO-QOL Taiwan version questionnaires for patients
      receiving LAVH. Assessment will be performed before operation; and 3 days, 7 days, 3 months
      and 18 months after operation. From these assessments, we plan to determine which QOL
      variables will be useful as operation guidelines for patients suffering from leiomyoma or
      adenomyosis, and for the assessment of appropriates and outcomes of LAVH.
    


Study Type

Observational




Condition

Leiomyoma

Intervention

questionnaires


Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Behavioral

Estimated Enrollment

80

Start Date

June 2005

Completion Date

June 2005


Eligibility Criteria

        Inclusion Criteria:

        laparoscopic assisted vaginal hysterectomy leiomyoma adenomyosis-

        Exclusion Criteria:

        other types of operations other types of gynecological disease-
      

Gender

Female

Ages

21 Years - 80 Years

Accepts Healthy Volunteers

No

Contacts

Torng Pao-Ling, MD, PhD, 886223123456, [email protected]

Location Countries

Taiwan

Location Countries

Taiwan

Administrative Informations


NCT ID

NCT00155870

Organization ID

9200201773



Study Sponsor

National Taiwan University Hospital


Study Sponsor

Torng Pao-Ling, MD, PhD, Principal Investigator, Department of Obstetric and Gynecology, National Taiwan University Hospital


Verification Date

June 2005